EGCG exerts its anticancer effects by targeting multiple pathways in cervical cancer: it inhibits EMT and metastasis via ROS/Smad and EGF/EGFR signaling, regulates epigenetic regulators to reactivate tumor suppressor genes, and suppresses angiogenesis and matrix remodeling. The gene discussed is EGF; the disease is cervical carcinoma.